Anavex Life Sciences Corp.

Geneos Wealth Management Inc. AVXL

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

48,200

Value ($000)

172

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	172	0.0%	48,200	12/31/2025
2025 Q3	10/22/2025	377	0.0%	42,400	9/30/2025
2025 Q2	8/18/2025	415	0.0%	45,050	6/30/2025
2025 Q1	5/8/2025	389	0.0%	45,350	3/31/2025
2024 Q4	1/21/2025	578	0.0%	53,775	12/31/2024
2024 Q3	11/14/2024	388	0.0%	68,225	9/30/2024
2024 Q2	7/23/2024	379	0.0%	89,725	6/30/2024
2024 Q1	5/3/2024	379	0.0%	74,400	3/31/2024
2023 Q4	1/26/2024	629	0.0%	67,600	12/31/2023
2023 Q3	10/11/2023	276	0.0%	42,100	9/30/2023
2023 Q2	8/8/2023	342	0.0%	42,100	6/30/2023
2023 Q1	4/25/2023	361	0.0%	42,100	3/31/2023
2022 Q4	1/31/2023	371	0.0%	40,100	12/31/2022
2022 Q3	11/14/2022	345	0.0%	33,500	9/30/2022
2022 Q2	7/22/2022	399	0.0%	38,800	6/30/2022
2022 Q1	5/16/2022	389	0.0%	31,650	3/31/2022
2021 Q4	2/9/2022	389	0.0%	22,450	12/31/2021
2021 Q3	11/9/2021	402	0.0%	22,450	9/30/2021
2021 Q2	7/8/2021	528	0.0%	21,500	6/30/2021
2021 Q1	6/17/2021	308	0.0%	25,500	3/31/2021
2020 Q4	5/19/2021	366	0.0%	24,500	12/31/2020
2020 Q3	9/7/2021	92	0.0%	24,000	9/30/2020
2020 Q2	9/7/2021	71	0.0%	14,000	6/30/2020
2020 Q1	9/7/2021	40	0.0%	14,000	3/31/2020
2019 Q4	9/7/2021	35	0.0%	14,000	12/31/2019
2019 Q3	9/7/2021	46	0.0%	14,000	9/30/2019
2019 Q2	9/7/2021	47	0.0%	14,000	6/30/2019
2019 Q1	9/7/2021	42	0.0%	14,000	3/31/2019
2018 Q4	9/7/2021	21	0.0%	14,000	12/31/2018
2018 Q3	9/7/2021	38	0.0%	14,000	9/30/2018